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The Fin1 protein of the yeast Saccharomyces cerevi-
siae forms filaments between the spindle pole bodies of
dividing cells. In the two-hybrid system it binds to 14-3-3
proteins, which are highly conserved proteins involved
in many cellular processes and which are capable of
binding to more than 120 different proteins. Here, we
describe the interaction of the Fin1 protein with the
14-3-3 proteins Bmh1p and Bmh2p in more detail. Puri-
fied Fin1p interacts with recombinant yeast 14-3-3 pro-
teins. This interaction is strongly reduced after dephos-
phorylation of Fin1p. Surface plasmon resonance
analysis showed that Fin1p has a higher affinity for
Bmh2p than for Bmh1p (KD 289 versus 585 nM). Se-
quences in both the central and C-terminal part of Fin1p
are required for the interaction with Bmh2p in the two-
hybrid system. In yeast strains lacking 14-3-3 proteins
Fin1 filament formation was observed, indicating that
the 14-3-3 proteins are not required for this process.
Fin1 also interacts with itself in the two-hybrid system.
For this interaction sequences at the C terminus, con-
taining one of two putative coiled-coil regions, are suf-
ficient. Fin1p-Fin1p interactions were demonstrated in
vivo by fluorescent resonance energy transfer between
cyan fluorescent protein-labeled Fin1p and yellow fluo-
rescent protein-labeled Fin1p.
The Saccharomyces cerevisiae FIN1 gene encodes a protein of
291 amino acids with a predicted pI of 10 that contains two
putative coiled-coil regions at its C terminus. We showed re-
cently (1) that the subcellular localization of the GFP1-Fin1
protein is highly cell cycle-dependent (1). In large budded cells
the protein is visible as a filament between the two spindle pole
bodies. In resting cells the protein is undetectable, and in small
budded cells it is localized in the nucleus. During late mitosis it
localizes on the spindle pole bodies. Purified His6-tagged Fin1p
self-assembles into filaments with a diameter of 10 nm after
dialysis against low salt buffers as is observed for other inter-
mediate filament-forming proteins. The Fin1 protein is an in-
teraction partner of the yeast 14-3-3 protein Bmh2 (1).
The 14-3-3 proteins form a family of highly conserved acidic
dimeric proteins that are present, often in multiple isoforms, in
all eukaryotic organisms (for review see Refs. 2–6). They bind
to more than 120 different proteins and play a role in the
regulation of many cellular processes, including signaling, cell
cycle control, apoptosis, exocytosis, cytoskeletal rearrange-
ments, transcription, and regulation of enzymes. Although the
exact function of the 14-3-3 proteins is still not completely
understood, three main mechanisms seem to be important.
First, 14-3-3 proteins positively or negatively regulate the ac-
tivity of enzymes; second, 14-3-3 proteins may act as localiza-
tion anchors, controlling the subcellular localization of pro-
teins; and third, 14-3-3 proteins can function as adaptor
molecules or scaffolds, thus stimulating protein-protein inter-
actions. Binding motifs have been identified in a number of
proteins that bind to the 14-3-3 proteins. Many of these binding
motifs consist of a phosphorylated serine residue, flanked by a
proline and arginine residue (7–9). However, other 14-3-3 bind-
ing motifs have been identified that are seemingly unrelated
and do not contain a phosphoserine (10, 11).
The yeast S. cerevisiae has two genes, BMH1 and BMH2,
encoding 14-3-3 proteins (12–15). A bmh1 bmh2 disruption is
lethal in most but not all laboratory strains, and the lethal
bmh1 bmh2 disruption can be complemented by at least four of
the Arabidopsis isoforms and by a human and Dictyostelium
isoform (16). As in higher eukaryotes, the S. cerevisiae 14-3-3
proteins are involved in many cellular processes, and many
different binding partners have been identified (14), including
the protein kinases Ste20p (17) and Yak1p (18) and the tran-
scription factors Rtg3 (19), Msn2, and Msn4 (20). Recently, it
has been shown (21) that the yeast 14-3-3 proteins bind to
cruciform DNA.
Here, we describe the two-hybrid screen identifying the Fin1
protein as an interaction partner of the Bmh2 protein and
detailed studies on the interaction between of the Fin1 protein
and the yeast 14-3-3 proteins. In addition, the self-association
of Fin1p was studied using both the yeast two-hybrid system
and fluorescence resonance energy transfer in intact yeast
cells.
MATERIALS AND METHODS
Strains, Culture Media, and Plasmids—S. cerevisiae HF7c (22) was
used as reporter strain in two-hybrid screens. S. cerevisiae strain
GG3100 is CEN-PK113-5D (MATa ura3–52; P. Ko¨tter, Go¨ttingen, Ger-
many) containing plasmid pRUL182. The bmh1 bmh2 strain RR1249
and the isogenic control strain F3 were obtained from Dr. G. R. Fink
(MIT, Cambridge, MA) (17). GG3066 expressing both CFP-Fin1 and
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YFP-Fin1, was constructed by transformation of CENPK113–3B
(MAT ura3–52 his3; P. Ko¨tter, Go¨ttingen, Germany) with the plasmids
pRUL1005 (1) and pRUL1008. The control strain GG3087 expressing
free CFP and free YFP was constructed by transformation of
CENPK113–3B with the plasmids pRUL1001 (1) and pRUL1004. Esch-
erichia coli (strain XL1-blue) and yeast were cultured as described
before (13). The plasmids constructions are listed in Table I. The se-
quences of the oligonucleotides used are shown in Table II.
Nucleic Acid Manipulations—Nucleic acid manipulations were per-
formed by standard techniques. The QIAprep mini spin kit (Qiagen)
was used to isolate plasmid DNA from E. coli. The same kit was used to
purify plasmid DNA from S. cerevisiae, after yeast cells were incubated
with 1 mg/ml lyticase in buffer P1 (Qiagen) for 30 min. Subsequently,
the isolated plasmid DNA was amplified in E. coli XLI-blue.
Two-hybrid Screen—Library Y2HL (22), consisting of 0.5–3-kb frag-
ments of genomic DNA fused to the GAL4ad, was a gift of Philip James.
Strain HF7c was first transformed (23) with pRUL551 and subse-
quently with 50 g of each of the libraries Y2HL-C1, Y2HL-C2, and
Y2HL-C3. Transformants with an activated HIS3 reporter were se-
lected on MY medium supplemented with adenine (20 g/ml), lysine (30
g/ml), and 20 mM 3-aminotriazole and subsequently assayed for -ga-
lactosidase activity. Library plasmids were isolated from His -galac-
tosidase transformants by amplification in E. coli after selection for
ampicillin resistance.
Purification of Bmh1p and Bmh2p—His6-tagged recombinant
Bmh1p and Bmh2p were purified from E. coli XLI containing pRUL526
and pRUL527, respectively. Cells were grown to an A620 of 0.25 in TB
supplemented with ampicillin. After addition of isopropyl-1-thio--D-
galactopyranoside to a final concentration of 1 mM, the cells were grown
for an additional 2.5 h to an A620 of 0.82. Two grams (wet weight) of cells
were harvested by centrifugation, resuspended in 15 ml of 50 mM
sodium phosphate buffer, pH 7.8, containing 300 mM NaCl, 1 mg/ml
lysozyme, 10 g/ml RNase A, and 10 g/ml DNase I and incubated for
30 min at 0 °C. Then Triton X-100 was added to a final concentration of
0.1%, and the cells were incubated on ice for an additional 10 min. The
lysate was cleared by two centrifugation steps at 13,000  g for 10 min
at 4 °C. One ml of nickel-nitrilotriacetic acid-agarose suspension (Qia-
gen) was added to the lysate, and after a 90-min incubation at 4 °C
under continuous stirring the mixture was poured into a column. The
column was washed with 100 ml of 50 mM phosphate buffer, pH 7.8, 300
mM NaCl, at 20 ml/h, followed by washing with 55 ml of Buffer B (50 mM
phosphate buffer, pH 6.5, 300 mM NaCl, 10% glycerol). The His6-tagged
proteins were eluted with a 40-ml 0–500 mM gradient of imidazole in
Buffer B. Fractions containing the purified His6-Bmh1p or His6-Bmh2p
were dialyzed against 50 mM phosphate buffer, pH 7.5, 50% glycerol,
300 mM NaCl. Protein concentrations were determined by Bradford
analysis (24), and purity was estimated by SDS-PAGE followed by
Coomassie and silver staining. The purified proteins were stored at
80 °C.
Purification of His6-Fin1p—S. cerevisiae strain GG3100 was grown
TABLE I
Plasmid constructions
Plasmid Features/construction
pGAD-C1, -C2, and -C3 Two hybrid vectors for the expression of Ga14 activating domain fusion proteins (22)
pGBDK-C1, -C2, and -C3 Two-hybrid vectors containing a kanamycin resistance marker. Constructed from pGBD-C1, -C2, and -C3 (22),
respectively, by replacing a AatII-BglI fragment containing the larger part of the ampicillin resistance marker
by a 1.2-kb AatII-BglI fragment with the kanamycin resistance marker from plasmid pRUL531 using a linker
consisting of oligonucleotides MH-1 and MH-2.
pMVHis Plasmid allowing the galactose-inducible expression of His6-tagged proteins in yeast. A synthetic DNA fragment
consisting of oligonucleotides MH-5 and MH-6 was ligated in the BamHI-HindIII sites of pYES2 (Invitrogen).
pUG36[FIN1] Plasmid allowing the expression of a N-terminal GFP-Fin1 fusion protein under control of the MET25
promoter (1).
pRUL182 Plasmid allowing the expression of a N-terminal His6 Fin1p fusion protein in yeast. The 0.9-kb BamHI-SalI
fragment from pRUL557, containing FIN1, was cloned in the BglII-XhoI sites of pMVHis.
pRUL348 Library plasmid isolated during a two-hybrid screen with BMH2 as bait. Encodes a fusion between the GAL4
activating domain and FIN1, lacking the first 30 bp.
pRUL360 pGAD plasmid with part of FIN1 isolated during a two-hybrid screen with FIN1.
pRUL361 pGAD plasmid with part of FIN1 isolated during a two-hybrid screen with FIN1.
pRUL362 pGAD plasmid with part of FIN1 isolated during a two-hybrid screen with FIN1.
pRUL366 pGAD plasmid with part of FIN1 constructed from pRUL348 by deleting a 1.3-kb XhoI-SalI fragment.
pRUL367 pGAD plasmid with part of FIN1 constructed from pRUL348 by deleting a 1.8-kb StuI-MscI fragment.
pRUL368 pGAD plasmid with part of FIN1 constructed by insertion of a synthetic DNA fragment consisting of
oligonucleotides MH-9 and MH-10 in the EcoRI-PstI sites of pGAD-C1.
pRUL369 pGAD plasmid with part of FIN1. A synthetic DNA fragment consisting of oligonucleotides MH-9 and MH-10 was
digested with TaqI and inserted in the EcoRI-ClaI sites of pGAD-C1.
pRUL370 pGAD plasmid with part of FIN1. Made by insertion of a linker consisting of oligonucleotides MH-11 and MH-12 in
the EcoRI-PstI sites of pGAD-C1.
pRUL371 pGAD plasmid with part of FIN1. A 1.3-kb XhoI-BglII fragment of pRUL348 was replaced by a fragment generated
by PCR with primers MH-13 and MH-14 on pRUL348, followed by digestion with XhoI and BglII.
pRUL372 pGBDK plasmid with part of FIN1. A 102-bp EcoRI-BglII fragment from pRUL369 was cloned in pGBDK-C1.
pRUL526 Plasmid allowing the expression of a N-terminal His6 Bmh1p fusion protein in E. coli. A 1-kb HinCII-SalI
fragment with BMH1 from plasmid pRS306[BMH1] (13) was ligated into the SmaI-SalI sites of pQE-30
(Qiagen).
pRUL527 Plasmid allowing the expression of a N-terminal His6-Bmh2p fusion protein in E. coli. The BMH2-containing
BamHI-SalI fragment from plasmid pRUL532 was cloned in the BamHI-SalI sites of pQE-32 (Qiagen).
pRUL532 Plasmid with BMH2 open reading frame. BamHI and SalI restriction sites were introduced at the ends of the
BMH2 open reading frame by PCR on plasmid pBlue[BMH2] (13) using primers MH-3 and MH-4. The resulting
fragment was ligated into the BamHI-SalI sites of pUC18.
pRUL551 pGBDK plasmid with BMH2. The BMH2-containing BamHI-SalI fragment from pRUL532 was cloned in
pGBDK-C2.
pRUL557 Plasmid with the FIN1 open reading frame. A BamHI site was introduced directly upstream of the FIN1 start
codon and a SalI site 42 bp downstream of the stop codon by PCR on genomic DNA from S. cerevisiae strain
S288c, using primers MH-7 and MH-8. This 0.9-kb PCR product was ligated into the BamHI-SalI sites of
pUC18.
pRUL558 pGBDK plasmid with FIN1. The 0.9-kb BamHI-SalI fragment with FIN1 from pRUL557 was cloned in pGBDK-C2.
pRUL1004 Plasmid suitable for expression of YFP fusion proteins. The GFP-containing XbaI-BamHI fragment of plasmid
pUG36 was replaced by a YFP-containing fragment. The latter fragment was made by PCR on plasmid pDH5 (D.
Haley, Yeast Resource Center, University of Washington, Seattle, WA) as described previously (1).
pRUL1008 Plasmid encoding YFP-Fin1p. The FIN1 open ready frame was cloned into pRUL1004 as described previously (1).
pRUL1072 pGAD plasmid with part of FIN1 made by cloning a PCR fragment obtained by using the primers FIN1-K and
FIN1-B into pGAD-C1 digested with ClaI and BglII.
pRUL1070 pGAD plasmid with part of FIN1 made by cloning a PCR fragment obtained by using the primers FIN1-G and
FIN1-B into pGAD-C1 digested with ClaI and BglII.
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in 500 ml of MY medium to an A620 of 0.8. Cells were harvested, washed,
and cultured for 16 h in 500 ml of MYZ medium supplemented with 1%
galactose to induce the expression of the recombinant protein. Cells
were harvested by centrifugation, and the pellet (3.8 g) was vortexed
with 4 g of glass beads (600 m; Sigma) in 40 ml of lysis buffer (8 M urea,
50 mM Tris-HCl, pH 8, 500 mM NaCl, 2 mM 2-mercaptoethanol) con-
taining 1 mM phenylmethylsulfonyl fluoride, 2 g/ml pepstatin A, 2
g/ml chymostatin, 1 mM -aminocaproic acid, 1 g/ml E-64, 1 g/ml
leupeptin, 2 g/ml aprotonin, and 1 mM Na3VO4. Cell debris was re-
moved by centrifugation for 10 min at 13,000  g, and the pH of the
clear supernatant was adjusted to 8.0 with NaOH. The extract was
incubated with 500 l of nickel-nitrilotriacetic acid-agarose (Qiagen) for
16 h at room temperature. All washing and elution steps were per-
formed in spin columns. The nickel-nitrilotriacetic acid-agarose was
washed six times with 0.5 ml of lysis buffer, 10 times with 0.5 ml of lysis
buffer containing 10 mM imidazole, and single times with 0.5 ml of lysis
buffer containing 20, 30, and 40 mM imidazole. His6-Fin1p was eluted
with 0.5 ml of lysis buffer containing 400 mM imidazole. The eluted
protein was dialyzed against 50 mM phosphate buffer, pH 7.5, 500 mM
NaCl, 50% glycerol at 4 °C. Alternatively, the protein was stored at
20 °C in the 8 M urea-containing elution buffer. The protein concen-
tration was determined with the Bradford assay, and purity was esti-
mated by SDS-PAGE and Coomassie staining.
Enzyme-linked Immunosorbent Assay (ELISA)—Microtiter plates
(Flow Laboratories) were coated overnight at 4 °C with varying
amounts of purified His6-Fin1p or cytochrome c (Sigma) in 50 l of PBS
(50 mM phosphate buffer, pH 7.5, 150 mM NaCl). After washing with
200 l of PBS, the wells were blocked with 200 l of 1% blocking reagent
(Roche Molecular Biochemicals) in PBS for 90 min at room tempera-
ture. When desired, bound Fin1p was dephosphorylated by incubation
with 100 units of  protein phosphatase (New England Biolabs) in 100
l of  protein phosphatase buffer for 60 min at 30 °C. Controls con-
tained heat-inactivated protein phosphatase (10 min at 100 °C in the
presence of 100 mM EDTA, pH 8.0). After five washes with 200 l of
PBST (PBS, 0.5% blocking reagent, 0.05% Tween 20), the wells were
incubated with 50 l of PBS containing the indicated amounts of puri-
fied His6-Bmh1p or His6-Bmh2p for 1 h at room temperature. The wells
were washed five times with 200 l of PBST, and 100 l of anti-Bmh1
antiserum (13) (1:2000) in PBST was added followed by a 1-h incubation
at room temperature. After washing with PBST, goat anti-rabbit IgG
alkaline phosphatase conjugate (Promega) and nitrophenylphosphate
were used to detect bound antiserum. Bound Fin1p was detected by a
similar procedure except that anti-RGSH4 antibody (Qiagen) and anti-
mouse/rabbit IgG-peroxidase (Roche Molecular Biochemicals) were
used.
Surface Plasmon Resonance Measurements—Surface plasmon reso-
nance analysis was done with a BIAcore-3000. 2000 resonance units of
Fin1p were coupled to a CM5 sensor chip (BIAcore) by the N-hydroxy-
succinimide/N-ethyl-N-(3-dimethylaminopropyl)carbodiimide hydro-
chloride (NHS/EDC) method (25). Fin1p was dialyzed against 2.5 mM
phosphate buffer, pH 7.5, 25 mM NaCl. The reference channel was made
by activating and deactivating the surface without coupling a protein.
Measurements were done in HBS buffer (BIAcore) at 25 °C at a flow
rate of 30 l/min. Each run consisted of an association step of 5 min
using either His6-Bmh1p or His6-Bmh2p dissolved in HBS, followed by
a dissociation step with HBS buffer. Between runs the chip was regen-
erated with 10 mM glycine, pH 10. Analysis of kinetic data was per-
formed with the BIAevaluate 3.0 software (BIAcore) using the 1:1
(Langmuir) binding fitting model. Simulations with experimentally
found kinetic parameters were done with BIAsim (BIAcore) and Clamp
software (26).
FRET Analysis—Yeast cells were cultured in MY medium, and ex-
ponentially growing cells were analyzed using a Zeiss Axiovert 135 TV
microscope (Zeiss, Jena, Germany), equipped with a 100-watt mercury
lamp and a 100/NA 1.30 Plan Neofluar phase objective. YFP was
detected with a filter set consisting of a 500/20-nm bandpass filter, a
515-nm dichroic mirror, and a 535/30-bandpass emission filter. For
FRET images the emission filter of the YFP filter set was used in
combination with the CFP excitation filter and dichroic mirror. CFP
was detected with a filter set consisting of a 436/20-nm bandpass
excitation filter, a 455-nm dichroic mirror, and a 480/20-nm bandpass
emission filter (all from Chroma Technologies). Images were acquired
using a cooled CCD camera (Princeton Instruments), in the sequence
YFP-, FRET-, and CFP-image (27). Typical exposure times were 0.2 s.
The set of three images was corrected for background and, when nec-
essary, for pixel shift. Overlap from the CFP and YFP into the FRET
image was corrected at each pixel. Images were further processed with
in-house software. For calculation of relative FRET values the formula,
FRETC  (IFRET  a * ICFP  b * IYFP)/ICFP, essentially as described
(28), was used, where FRETC is the corrected FRET value, and IFRET,
ICFP, and IYFP are intensities measured through FRET, CFP, and YFP
filter sets, respectively. a and b are bleed-through percentages meas-
ured in cells only expressing CFP or YFP. Calculated FRETC values are
displayed in pseudocolor.
RESULTS
Identification of Fin1p as a Binding Partner for Bmh2p—To
identify binding partners of the yeast 14-3-3 protein Bmh2 we
made use of the two-hybrid system. To facilitate analysis of
positive clones, we constructed “bait” and “prey” vectors with a
different selection marker. Therefore, we replaced the ampicil-
lin resistance marker of bait vectors pGBD-C1, pGBD-C2, and
pGBD-C3 (22) by the kanamycin resistance marker. Then, we
constructed plasmid pRUL551 encoding a fusion between
Bmh2p and Gal4bd. This construct was able to complement a
lethal bmh1 bmh2 disruption, indicating that the fusion pro-
tein has retained (at least) its essential 14-3-3 function (data
not shown). pRUL551 alone already activated the HIS3 re-
porter of HF7c, but this could be suppressed by addition of 20
mM 3-aminotriazole. Of 22  106 transformants, five had both
an active HIS3 and -galactosidase reporter.
We isolated plasmids from the His -galactosidase trans-
formants, and after transformation of E. coli, colonies were
selected on medium supplemented with ampicillin. None of
these E. coli colonies contained the bait plasmid pRUL551. In
two other two-hybrid screens using bait plasmids with a kana-
TABLE II
Oligonucleotide sequences
MH-1 GTCAAGCTTCGAGTTCa
MH-2 CTCGAAGCTTGACTTC
MH-3 CGGGATCCAAATGTCCCAAACTCGT
MH-4 GCGTCGACCCCCTTGTATTTCTCAG
MH-5 AGCTAAAATGAGAGGTTCTCATCACCATCACCATCACAGATCTCACGTGTTGGCCATCCCGGG
MH-6 GATCCCCGGGATGGCCAACACGTGAGATCTGTGATGGTGATGGTGATGAGAACCTCTCATTTT
MH-7 CGGGATCCATGAGCAATAAAAGCAACCG
MH-8 ACGCGTCGACCTTGCTTACTTCCTGTGTAA
MH-9 AATTCGTGGAACTTAAAGAAATAAAGGACTTGCTACTACAAATGTTGAGAAGACAGCGAGAGA
TTGAATCAAGATTATCCAATATCGAACTTCAACTCACGGAAATACCGAAACATAAGTAACTGCA
MH-10 GTTACTTATGTTTCGGTATTTCCGTGAGTTGAAGTTCGATATTGGATAATCTTGATTCAATCTC
TCGCTGTCTTCTCAACATTTGTAGTAGCAAGTCCTTTATTTCTTTAAGTTCCACG
MH-11 AATTCATGTTGAGAAGACAGCGAGAGATTGAATCAAGATTATCCAATATCGAACTTTAAGCTTGTGCA
MH-12 CAAGCTTAAAGTTCGATATTGGATAATCTTGATTCAATCTCTCGCTGTCTTCTCAACATG
MH-13 GGTGATGGTTCGTTAACGAG
MH-14 GAAGATCTAAGCTTAGGTTTCTTCAGTCACTATATTAT
FIN1-B GAAGATCTTTACTTATGTTTCGGTATTTCC
FIN1-G CCATCGATGGAATGAAGCATAGTATA
FIN1-K CCATCGATAAGACAGATGGAATGAAGCAT
a All sequences are given 5 to 3.
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mycin marker we did not isolate the bait plasmid either (data
not shown), indicating the power of the use of different selec-
tion markers in the bait and prey plasmids. Cotransformation
of HF7c with each of the five isolated library plasmids and
pRUL551 resulted again in His transformants with -galac-
tosidase activity. Cotransformation of HF7c with the isolated
library plasmids and the empty vector pGBDK-C1 yielded His
transformants without -galactosidase activity. This demon-
strates that the activation of the reporter genes of HF7c in
these five positives is dependent on the presence of both
pRUL551 and the library plasmid. Sequencing of the yeast
DNA insert of one of the isolated plasmids revealed an in-frame
fusion between the GAL4ad and the 3-end of GCR2, encoding
amino acids 223 to 534 of the Gcr2 protein. GCR2 encodes a
transcription factor required for full activation of glycolytic
genes. Three other plasmids contain SPT21. However, for
SPT21 there is not an in-frame fusion with the GAL4 activat-
ing domain. The last plasmid contains an in-frame fusion be-
tween the GAL4ad and YDR130c, lacking the first 30 base
pairs. As the protein encoded by this open reading frame forms
cell cycle-specific filaments, we named this open reading frame
FIN1 (filaments in between nuclei 1) (1). The reverse combina-
tion, BMH2 fused to the GAL4ad and FIN1 fused to GAL4bd,
also reacts positively in the two-hybrid system (data not
shown). We studied the interaction between Fin1p and the
yeast 14-3-3 proteins in more detail.
In Vitro Interaction between the Yeast 14-3-3 Proteins and
Fin1p—To confirm the interaction between the 14-3-3 proteins
and Fin1p found in the two-hybrid system, we used a sandwich
ELISA with purified proteins. To this end we isolated recom-
binant His6-tagged Bmh1 and Bmh2 proteins from E. coli and
His6-tagged Fin1p from yeast (see “Materials and Methods”).
Various amounts of purified Fin1p (0–200 ng) were immobi-
lized to the wells of a microtiter plate. After blocking and
washing, these wells were incubated with Bmh1p or Bmh2p,
and the amount of Bmh protein bound was determined immu-
nologically using our anti-14-3-3 protein antiserum (13). Fig. 1
shows that increasing the amount of immobilized Fin1p re-
sulted in increased binding of Bmh1 and Bmh2p ( and f,
respectively). In the absence of a Bmh protein, no signal was
observed (Fig. 1, E). The apparent stronger binding of Bmh1p
in comparison to Bmh2p is not caused by a higher affinity of
Bmh1p for Fin1p (as will be discussed later) but is because of
the higher affinity of the anti-14-3-3 antiserum for Bmh1p. As
Fin1p is a highly basic protein, whereas the 14-3-3 proteins are
acidic, we also performed an ELISA experiment in which we
used another basic protein, cytochrome c, instead of Fin1p. As
shown in Fig. 1 (Œ), Bmh2p does not bind to cytochrome c.
Similar results were obtained for Bmh1p (data not shown),
demonstrating that there is a specific in vitro interaction be-
tween the yeast 14-3-3 proteins and Fin1p.
Surface Plasmon Resonance Analysis—The dissociation con-
stants of the Fin1p-Bmh1p and Fin1p-Bmh2p interactions
were determined by surface plasmon resonance analysis. To
this end 2000 resonance units of Fin1p were covalently immo-
bilized to the surface of a CM5 sensor chip, and solutions with
various concentrations of Bmh1p or Bmh2p were injected over
the chip. A relatively fast binding of Bmh1p or Bmh2p to Fin1p
was observed, whereas dissociation was relatively slow (Fig. 2).
Dissociation was not affected by addition of 2 M NaCl, 2 M KCl,
or 2 M LiCl to the buffer, indicating that the Bmh-Fin1p inter-
action is resistant to high salt concentrations (data not shown).
Using the 1:1 Langmuir binding model, we calculated for
Bmh1p an association rate constant (ka) of 1.85  10
3 M1 s1
and a dissociation rate constant (kd) of 1.08  10
3 s1 and for
Bmh2p a ka of 2.57  10
3 M1 s1 and a kd of 7.44  10
4 s1.
In these calculations we included our observation that the
recombinant Bmh proteins form dimers (data not shown).
These data resulted in a dissociation constant (KD) of 585 nM
for the Fin1p-Bmh1p interaction and of 289 nM for the Fin1p-
Bmh2p interaction, indicating that Bmh2p has a higher affin-
ity than Bmh1p for Fin1p. Simulated curves obtained by using
the found dissociation constants matched with the experimen-
tal curves.
Effect of Dephosphorylation on the Bmh2p-Fin1p Interac-
tion—Western blot analysis with an antibody recognizing phos-
FIG. 1. ELISA to study the binding of Bmh1p and Bmh2p to
Fin1p. Increasing amounts of purified His6-Fin1p or cytochrome c (Œ)
were coated to the wells of a microtiter plate. After blocking and wash-
ing, the wells were incubated with a solution containing 2 g Bmh2p (f
and Œ), 2 g Bmh1p (), or no protein (E). The amount of 14-3-3 protein
retained in the wells after washing was determined immunologically
(A415).
FIG. 2. Overlay plots of sensograms of Bmh1p (A) or Bmh2p (B)
binding to immobilized Fin1p during surface plasmon reso-
nance analysis. Two thousand resonance units of purified Fin1p were
immobilized to a CM5 chip. Solutions containing the indicated concen-
trations of Bmh1p or Bmh2p were applied to allow binding (associa-
tion). For dissociation buffer without protein was used.
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phorylated serine, threonine, and tyrosine residues suggested
that Fin1p is a (partly) phosphorylated protein (data not
shown). To study the role of Fin1p phosphorylation in the
interaction with the 14-3-3 proteins, increasing amounts of
Fin1p (0–250 ng) were immobilized to the wells of a microtiter
plate, and the immobilized Fin1p in one series of wells was
treated with the nonspecific  protein phosphatase. As a con-
trol, the other series of wells was incubated with inactivated
protein phosphatase. As shown in Fig. 3 (), Bmh2p binds to
Fin1p treated with inactive phosphatase in a similar way as
untreated Fin1p. However, treatment of Fin1p with protein
phosphatase resulted in a strong reduction in Bmh2p binding
(Fig. 3, Œ). The reduced binding of Bmh2p to Fin1p after
dephosphorylation was not caused by a decrease in the amount
of immobilized Fin1p, as the amount of immobilized Fin1p was
not affected by the protein phosphatase treatment (Fig. 3, E
and f). Similar results were obtained with Bmh1p (data not
shown). In addition, during surface plasmon resonance analy-
sis dephosphorylation of Fin1p resulted in a strong reduction
(60%) of the Bmh2p binding (data not shown).
Fin1p Filament Formation in Cells Deficient in 14-3-3 Pro-
teins—The Fin1 protein forms cell cycle-specific filaments be-
tween the spindle pole bodies of dividing yeast cells. To study
the role of the 14-3-3 proteins in Fin1p filament formation we
made use of the observation that in 1288-derived strains the
14-3-3 proteins are not essential (17). To this end the bmh1
bmh2 strain RR1249 and the isogenic control strain F3 were
transformed with plasmid pUG36[FIN1] encoding an N-termi-
nal GFP fusion of Fin1p. As shown in Fig. 4, in both strains
fluorescent filaments can be seen. In theory it is possible that
in the 1288-derived strains the loss of 14-3-3 proteins is
compensated by an unknown activity that replaces the 14-3-3
proteins during Fin1p filament formation. Therefore, we also
looked at Fin1p filament formation in a strain in which BMH1
and BMH2 are replaced by a temperature-sensitive bmh2 allele
(19). Both at the permissive and restrictive temperature, fila-
ments formed by GFP-Fin1 were observed (data not shown).
Also in a strain in which both BMH1 and BMH2 are replaced
by cDNA encoding a plant 14-3-3 protein isoform under control
of the GAL1 promoter (13), GFP-Fin1 filaments were observed
after growth on medium with glucose as sole carbon source
resulting in undetectable levels of 14-3-3 proteins (data not
shown). These results indicate that the 14-3-3 proteins are not
essential for Fin1p filament formation in vivo, in agreement
with our previous observation that purified Fin1p forms fila-
ments in vitro in the absence of other proteins.
Self-association of Fin1p—Transformation of reporter strain
HF7c with plasmids pRUL348 and pRUL558 encoding fusions
between of Fin1p (amino acids 11–291) with Gal4ad and
Gal4bd, respectively, yielded transformants that were able to
grow on medium without histidine and that displayed -galac-
tosidase activity (data not shown). In addition, during a two-
hybrid screen for interaction partners of Fin1p, we isolated
several clones containing a GAL4ad-FIN1 fusion (1). Therefore,
Fin1p is able to interact with itself in the two-hybrid system.
This observation is in agreement with our previous observation
(1) that purified His6-Fin1p self-assembles into 10-nm fila-
ments after dialysis against low salt buffers.
Mapping of the Fin1p Domains Responsible for Self-associa-
tion and Bmh2p Binding—To map the regions of Fin1p that
are involved in self-association and in the binding to the 14-3-3
proteins, plasmids were constructed that expressed in-frame
fusions of GAL4ad with various parts of FIN1 (Fig. 5). The N
terminus of Fin1p up to amino acid 253 could be deleted with-
out affecting the interaction with Gal4bd-Fin1p (Fig. 5). On the
other hand, deletion of the C-terminal part of Fin1p completely
abolished the interaction with Gal4bd-Fin1p (Fig. 5). A fusion
containing amino acids 266–282 was unable to interact with
Gal4bd-Fin1p. In contrast, a Gal4ad fusion protein containing
amino acids 254–280 of Fin1p (pRUL369) was able to interact
with both Gal4bd-Fin1p and with Gal4bd fused to amino acids
254–280 of Fin1p. These data indicate that amino acids 254–
280 of the C-terminal part of Fin1p are required for self-asso-
ciation and that this region alone is sufficient for this self-
association. This region contains one of the two putative coiled-
coil regions present in the Fin1 protein, suggesting that this
coiled-coil region is involved in the self-association. The inter-
action with Bmh2p was also completely abolished after deletion
of the C-terminal sequences of Fin1p. The interaction was not
disturbed after deletion of the first 56 amino acids from the N
terminus of Fin1p but was abolished after deletion of the first
58 amino acids from the N terminus, indicating that sequences
in this part of the Fin1 protein are involved in 14-3-3 binding.
This part of the protein does not contain sequences resembling
known 14-3-3 binding sequences. As 14-3-3 binding to Fin1p
was affected by dephosphorylation, we replaced the threonine
residue at position 58 by a valine residue. However, binding to
14-3-3 still occurred (data not shown). Our results suggest that
both sequences around residue 58 and the C-terminal part of
Fin1p are required for association with Bmh2p. Alternatively,
association with Bmh2p might require a dimeric Fin1p. In that
case, deletion of the C terminus disrupts the Fin1p self-associ-
ation, and deletion of sequences around residue 58 might re-
move the Bmh2p-binding domain.
FRET between CFP- and YFP-tagged Fin1 Proteins—FRET
FIG. 3. ELISA to study the effect of phosphatase treatment of
Fin1p on the interaction with Bmh2p. Increasing amounts of Fin1p
were immobilized to the wells of a microtiter plate. Two series of wells
were treated with either active (Œ and f) or inactivated ( and E) 
protein phosphatase. After blocking and washing, both series of wells
were incubated with a solution containing 1 g of Bmh2p. The amounts
of Bmh2p bound to Fin1p () and to dephosphorylated Fin1p (Œ) were
determined immunologically using anti-14-3-3 protein antiserum
(A415). To determine the effect of phosphatase treatment on the amount
of Fin1p present in the well, two other series of wells containing immo-
bilized Fin1p were treated with inactivated (E) and active (f) protein
phosphatase. Subsequently the amount of Fin1p was determined im-
munologically using anti-RGSH4 antibody (A492).
FIG. 4. Fluorescence microscopy of F3 (BMH1 BMH2) (A) and
RR1249 (bmh1 bmh2) (B) cells containing plasmid pUG36[FIN1]
expressing GFP-Fin1p.
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measurements were used to study the self-association of Fin1p
in the intact yeast cell. To this end strain GG3066 was con-
structed expressing both CFP-tagged Fin1p and YFP-tagged
Fin1p. Both labeled Fin1 proteins behaved similarly as we
reported for GFP-Fin1p (1). In the dividing cell shown in Fig.
6A, both CFP-Fin1p as YFP-Fin1p were present in the spindle
pole bodies. After correction for the spectral overlap of CFP and
YFP, a clear energy transfer from the CFP-tagged Fin1p to the
YFP-tagged Fin1p could be observed in the spindle pole bodies.
In the dividing cell shown in Fig. 6B, both CFP-Fin1p and
YFP-Fin1p were present in a filament between the spindle bole
bodies. Again energy transfer was observed, although less than
in the spindle pole bodies. No significant energy transfer was
observed in cells expressing both free CFP and YFP (Fig. 6C).
DISCUSSION
In this study we performed a two-hybrid screen to identify
interaction partners of the Bmh2 protein. One of the binding
partners was the Fin1 protein. While the manuscript was in
preparation interaction between Fin1p and the yeast 14-3-3
proteins has also been reported by others (29). Fin1p is a
291-amino acid protein of unknown function with a pI of 10
that contains two putative coiled-coil regions in the C terminus.
The protein is45% similar to myosins and tropomyosins from
various organisms. In addition, it shares 45% similar resi-
dues with parts of the kinesin-like proteins Kar3p from S.
cerevisiae and human CENP-E and CENP-F. We showed re-
cently (1) that Fin1p form cell cycle-specific filaments between
the spindle poles of dividing cells. In vitro, the protein can form
10-nm filamentous structures resembling the filaments formed
by other intermediate filament proteins. Here, we showed that
in the two-hybrid system sequences at the C terminus of the
Fin1 protein containing one of the two putative coiled-coil re-
gions are sufficient for self-association (Fig. 5). In addition, we
showed FRET between CFP-Fin1p and YFP-Fin1p in intact in
yeast cells (Fig. 6). The function of the Fin1p filaments is still
unknown. However, in the two-hybrid assay Fin1p interacts
not only with the 14-3-3 proteins and Fin1p itself but also with
Reb1p, Fir1p, and Wss1p (1). Both the Reb1 and Fir1 proteins
are involved in RNA metabolism. The Reb1 protein is a DNA-
binding protein required for termination of RNA polymerase I
transcription (30, 31), and the Fir1 protein (32) has been iden-
tified as a factor interacting with the Ref2 protein, which is
involved in 3mRNA processing (33). Wss1p is a weak suppres-
sor of a SMT3 mutation, a gene that may be involved in the
function and/or structure of the kinetochore (34). In a large
scale search for protein-protein interactions the Fin1 protein
was found to interact with the Glc7 protein phosphatase (35).
The yeast S. cerevisiae is widely used as model organism for
studies on cellular processes. We use this yeast to elucidate the
function of the 14-3-3 proteins. 14-3-3 proteins are present in
all eukaryotic organisms investigated, and more than 120 in-
teraction partners have been identified (for review see Refs.
2–6). These interaction partners belong to many different
classes of proteins, such as protein kinases, protein phosphata-
ses, receptors, transcription factors, filament-forming proteins,
and enzymes. In this study we identified the filament-forming
Fin1 protein as an interaction partner of the yeast 14-3-3
proteins. Previously, the protein kinase Ste20p and Yak1p and
the transcription factors Msn2p, Msn4p, and Rtg3p have been
identified as interaction partners for the yeast 14-3-3 proteins,
whereas a large scale analysis of yeast protein-protein interac-
tions (35) revealed interactions with the extracellular mem-
brane protein Ecm13p, with the inositolhexaphosphate kinase
Kcs1p and with Bop3p, overexpression of which can bypass
mutations in the phosphatase suppressor gene PAM1. Thus
also in the relatively simple yeast cell the 14-3-3 proteins have
different interaction partners, belonging to different classes of
proteins.
In a large number of proteins interacting with 14-3-3 pro-
teins specific binding motifs have been identified. Many of
these motifs contain a phosphorylated serine residue flanked
by a proline and arginine residue (7–9). The Fin1 protein does
FIG. 6. FRET between CFP-Fin1p and YFP-Fin1p in intact
yeast cells. Corrected FRET values (as described under “Materials and
Methods”) are displayed in pseudocolor. A, GG3036 cells, expressing
CFP-Fin1p and YFP-Fin1p, both localized in the spindle pole bodies; B,
GG3036 cells, expressing CFP-Fin1p and YFP-Fin1p, both localized in
a filament between the spindle pole bodies; C, GG3087 cells, expressing
free CFP and free YFP, both localized mainly in the cytoplasm; D,
relationship between color and pixel value.
TABLE III
Dissociation constants (KD) for the interactions between 14-3-3
proteins and a number of binding partners
Binding partner KD Reference
nM
Tyr-hydroxylase complete 3 42
H-ATPase AHA2 peptide 88 43
MEKK3 N-terminus 90 44
Raf-based peptides 122–145 7
Interleukin-3  chain peptide 152 45
Fin1p-Bmh2p 289 This study
Trp-hydroxylase 450 46
Fin1p-Bmh1p 585 This study
Tyr-hydroxylase peptide 81000 42
FIG. 5. Mapping of the Fin1p domains responsible for self-
association and interaction with Bmh2p using the two-hybrid
system. Various parts of Fin1p were expressed as Gal4ad fusion pro-
teins. These were tested for interaction with Gal4bd fusions containing
amino acids 11–291 of Fin1p (plasmid pRUL558), amino acids 254–280
of Fin1p (pRUL372), or full-length Bmh2p (pRUL551). A positive inter-
action, i.e. when a combination of bait and prey plasmid activated both
the HIS3 and -galactosidase reporter genes in strain HF7c, is indi-
cated with a plus sign (). Double transformants negative for both
reporter genes are indicated with a minus sign (). Dark boxes in Fin1p
indicate predicted coiled-coil regions.
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not contain any of these phosphoserine-containing motifs, nor
does it contain any of the previously defined 14-3-3 binding
motifs lacking a phosphorylated serine residue (10, 11). How-
ever, phosphorylation of the Fin1 protein is involved in 14-3-3
binding. Deletion studies suggested that both sequences
around residue 58 and in the C-terminal part of Fin1p are
required for association with Bmh2p. These results may imply
that multiple sites are responsible for 14-3-3 binding, that a
dimeric Fin1 protein is required, or that a truncated Fin1
protein does not fold correctly.
Using surface plasmon resonance analysis we have deter-
mined the dissociation constants of the Fin1p-Bmh1p and
Fin1p-Bmh2 interactions. These dissociation constants are in
the same range as those published for other 14-3-3 binding
partners (Table III). We showed that Bmh2p has a higher
affinity than Bmh1p for Fin1p. However, Bmh1p and Bmh2p
are for 97% identical over the first 250 amino acids. Therefore,
any isoform specificity probably resides in the divergent C
termini. The physiological significance of this difference in
affinity remains to be elucidated. In the yeast cell the differ-
ence in affinities might be counterbalanced by an 5-fold
higher Bmh1p concentration than Bmh2p concentration.2 In
literature mainly qualitative examples of isoform specificity
can be found. Muslin et al. (7) found little differences in the
affinity constants for the interaction between a number of
14-3-3 isoforms (, , , and ) and a Raf-based peptide. The
latter study was performed with short peptides, and we used a
complete protein. Besides a 14-3-3 binding motif, other parts of
the protein might be involved in modulating the interaction
(36).
In this study we showed that the yeast 14-3-3 proteins in-
teract with the intermediate filament protein Fin1p. Interac-
tions between the 14-3-3 proteins and other intermediate fila-
ment or cytoskeleton proteins have been reported (37–39). In
keratinocytes the keratin K8/K18 forms intermediate fila-
ments in a cell cycle-regulated way (40, 41). The 14-3-3 proteins
keep the keratin in a soluble form. The yeast 14-3-3 proteins
may have a similar function in Fin1p filament formation. As in
1288-derived strains filament formation was not affected by
the absence of 14-3-3 proteins, and the 14-3-3 proteins are not
essential for filament formation (Fig. 4).
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